← HDFC Mutual Fund

HDFC Large and Mid Cap Fund - Growth Option - Direct Plan

Mid Cap Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
237
Jun 2026
Equity Holdings
₹28,934.01 Cr
Equity only, excl. debt & cash
Top 5 Weight
13.1%
Diversified
Top 10 Weight
20.2%
Diversified
Changes
163
0 new · 0 exits
Top Sector
Banks
17.5% of portfolio
📋 What Happened This Month Among existing holdings, Alkem Laboratories Limited saw the biggest increase — now at 0.86% of the portfolio. Infosys Limited was trimmed the most, now at 1.10%. HDFC Bank Limited remains the top holding with Banks the dominant sector at 17.5%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Apr 2026 May 2026
Sector Prev Curr Delta
Banks 16.9% 17.0% +0.0%
Pharmaceuticals & Biotechnology 9.8% 10.1% +0.3%
Finance 8.0% 7.8% -0.2%
IT - Software 6.4% 6.4% +0.0%
Auto Components 4.2% 4.3% +0.1%
Automobiles 3.8% 3.9% +0.1%
Retailing 3.5% 3.4% -0.1%
Insurance 3.3% 3.4% +0.1%
Petroleum Products 2.3% 3.0% +0.7%
Power 2.8% 2.9% +0.0%
May 2026 Jun 2026
Sector Prev Curr Delta
Banks 17.0% 17.5% +0.5%
Pharmaceuticals & Biotechnology 10.1% 10.8% +0.6%
Finance 7.8% 8.2% +0.4%
IT - Software 6.4% 5.8% -0.7%
Auto Components 4.3% 4.3% +0.1%
Automobiles 3.9% 3.8% -0.1%
Retailing 3.4% 3.6% +0.1%
Insurance 3.4% 3.2% -0.2%
Petroleum Products 3.0% 2.9% -0.1%
Healthcare Services 2.7% 2.8% +0.1%
Biggest Add
Alkem Laboratories Limited
+0.26% · now 0.86%
Biggest Trim
Infosys Limited
-0.22% · now 1.10%

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 Jun 2026
↑ 68 Increased ↓ 95 Decreased
#StockSectorMay 2026Jun 2026Change
1
Alkem Laboratories Limited
₹251.44 Cr
Pharmaceuticals & Biotechnology 0.60% 0.86% +0.26%
2
ICICI Bank Limited
₹1,086.52 Cr
Banks 3.48% 3.71% +0.23%
3
HDFC Bank Limited
₹1,170.18 Cr
Banks 3.83% 4.00% +0.17%
4
InterGlobe Aviation Limited
₹262.29 Cr
Transport Services 0.75% 0.90% +0.15%
5
Ajanta Pharma Limited
₹307.09 Cr
Pharmaceuticals & Biotechnology 0.92% 1.05% +0.13%
6
Prestige Estates Projects Limited
₹391.15 Cr
Realty 1.25% 1.34% +0.09%
7
Gland Pharma Limited
₹349.30 Cr
Pharmaceuticals & Biotechnology 1.10% 1.19% +0.09%
8
Aurobindo Pharma Limited
₹341.00 Cr
Pharmaceuticals & Biotechnology 1.08% 1.16% +0.08%
9
Shriram Finance Limited
₹335.39 Cr
Finance 1.07% 1.15% +0.08%
10
Trent Limited
₹177.26 Cr
Retailing 0.53% 0.61% +0.08%
#StockSectorMay 2026Jun 2026Change
1
Infosys Limited
₹323.28 Cr
IT - Software 1.32% 1.10% -0.22%
2
Hindalco Industries Limited
₹229.20 Cr
Non - Ferrous Metals 0.95% 0.78% -0.17%
3
Persistent Systems Limited
₹171.83 Cr
IT - Software 0.72% 0.59% -0.13%
4
Max Financial Services Limited
₹412.16 Cr
Insurance 1.53% 1.41% -0.12%
5
Jindal Steel Limited
₹201.42 Cr
Ferrous Metals 0.80% 0.69% -0.11%
6
Steel Authority of India Limited
₹149.85 Cr
Ferrous Metals 0.62% 0.51% -0.11%
7
Mphasis Limited
₹332.45 Cr
IT - Software 1.23% 1.14% -0.09%
8
NTPC Limited
₹248.38 Cr
Power 0.94% 0.85% -0.09%
9
HCL Technologies Limited
₹207.77 Cr
IT - Software 0.80% 0.71% -0.09%
10
Reliance Industries Limited
₹443.31 Cr
Petroleum Products 1.59% 1.51% -0.08%

What Stocks Does This Fund Hold?

237 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
₹1,170.18 Cr
Banks
4.00%
2
₹1,086.52 Cr
Banks
3.71%
3
₹571.92 Cr
Banks
1.95%
4
₹538.26 Cr
Telecom - Services
1.84%
5
₹452.96 Cr
Healthcare Services
1.55%
6
₹443.31 Cr
Petroleum Products
1.51%
7
₹432.33 Cr
Banks
1.48%
8
₹414.20 Cr
Automobiles
1.41%
9
₹412.16 Cr
Insurance
1.41%
10
₹391.15 Cr
Realty
1.34%
🏆 Top stocks held by Mid Cap funds
See which stocks all active Mid Cap fund managers are buying — ranked by total value invested
🏦 HDFC Mutual Fund — Portfolio & Holdings
See all funds managed by HDFC Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.